High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 139, Issue 3, 2007, Pages 450-457

  Troeger, Anja ^a,b   Gudowius, Sonja ^b   Escherich, Gabriele ^c   Den Boer, Monique L ^e   Glouchkova, Ludmila ^b   Ackermann, Birgit ^b   Meisel, Roland ^b   Laws, Hans Juergen ^b   Groeger, Marketa ^b   Wessalowski, Ruediger ^b   Willers, Reinhart ^b   Harbott, Jochen ^d   Pieters, Rob ^e   Goebel, Ulrich ^b   Janka Schaub, Gritta E ^c   Hanenberg, Helmut ^b,f   Dilloo, Dagmar ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B cell precursor acute lymphoblastic leukaemia; Children; Flow cytometry; p75NTR; Prognosis

Indexed keywords

NERVE GROWTH FACTOR RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B LYMPHOCYTE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; LEUKOCYTE COUNT; MALE; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, NERVE GROWTH FACTOR; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 34848906811     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06818.x     Document Type: Article

References (61)

1. Aloe, L., Simone, M.D. Properzi, F. (1999) Nerve growth factor: a neurotrophin with activity on cells of the immune system. Microscopy Research and Technique, 45, 285 291.
2. Aragona, M., Panetta, S., Silipigni, A.M., Romeo, D.L., Pastura, G., Mesiti, M., Cascinu, S. La Torre, F. (2001) Nerve growth factor receptor immunoreactivity in breast cancer patients. Cancer Investigation, 19, 692 697.
3. Beutel, G., Meyer, J., Ma, L., Yin, S., Eder, M., von Neuhoff, N., Wilkens, L., Wei, J., Hertenstein, B., Heil, G., Schlegelberger, B., Ganser, A., Li, Z. Baum, C. (2005) Expression of the p75 neurotrophin receptor in acute leukaemia. British Journal of Haematology, 131, 67 70.
4. Bonini, S., Rasi, G., Bracci-Laudiero, M.L., Procoli, A. Aloe, L. (2003) Nerve growth factor: neurotrophin or cytokine?. International Archives of Allergy and Immunology, 131, 80 84.
5. Bono, F., Lamarche, I., Bornia, J., Savi, P., Della Valle, G. Herbert, J.M. (1999) Nerve growth factor (NGF) exerts its pro-apoptotic effect via the P75NTR receptor in a cell cycle-dependent manner. FEBS Letters, 457, 93 97.
6. Brodie, C. Gelfand, E.W. (1992) Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2. Journal of Immunology, 148, 3492 3497.
7. Brodie, C. Gelfand, E.W. (1994) Regulation of immunoglobulin production by nerve growth factor: comparison with anti-CD40. Journal of Neuroimmunology, 52, 87 96.
8. Casaccia-Bonnefil, P., Kong, H. Chao, M.V. (1998) Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death and Differentiation, 5, 357 364.
9. Chao, M., Casaccia-Bonnefil, P., Carter, B., Chittka, A., Kong, H. Yoon, S.O. (1998) Neurotrophin receptors: mediators of life and death. Brain Research. Brain Research Reviews, 26, 295 301.
10. Chesa, P.G., Rettig, W.J., Thomson, T.M., Old, L.J. Melamed, M.R. (1988) Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues. Journal of Histochemistry and Cytochemistry, 36, 383 389.
11. D'Onofrio, M., de Grazia, U., Morrone, S., Cuomo, L., Spinsanti, P., Frati, L., Gulino, A. Ragona, G. (2000) Expression of neurotrophin receptors in normal and malignant B lymphocytes. European Cytokine Network, 11, 283 291.
12. Den Boer, M.L., Harms, D.O., Pieters, R., Kazemier, K.M., Gobel, U., Korholz, D., Graubner, U., Haas, R.J., Jorch, N., Spaar, H.J., Kaspers, G.J., Kamps, W.A., Van der Does-Van den Berg, A., Van Wering, E.R., Veerman, A.J. Janka-Schaub, G.E. (2003) Patient stratification based on prednisolone- vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 21, 3262 3268.
13. Descamps, S., Pawlowski, V., Revillion, F., Hornez, L., Hebbar, M., Boilly, B., Hondermarck, H. Peyrat, J.P. (2001a) Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Research, 61, 4337 4340.
14. Descamps, S., Toillon, R.A., Adriaenssens, E., Pawlowski, V., Cool, S.M., Nurcombe, V., Le Bourhis, X., Boilly, B., Peyrat, J.P. Hondermarck, H. (2001b) Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. Journal of Biological Chemistry, 276, 17864 17870.
15. Eggert, A., Sieverts, H., Ikegaki, N. Brodeur, G.M. (2000) p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA. Medical and Pediatric Oncology, 35, 573 576.
16. Ehrhard, P.B., Erb, P., Graumann, U., Schmutz, B. Otten, U. (1994) Expression of functional trk tyrosine kinase receptors after T cell activation. Journal of Immunology, 152, 2705 2709.
17. Fiorentini, C., Facchetti, M., Finardi, A., Sigala, S., Paez-Pereda, M., Sher, E., Spano, P. Missale, C. (2002) Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. European Journal of Endocrinology, 147, 371 379.
18. Friedman, W.J. Greene, L.A. (1999) Neurotrophin signaling via Trks and p75. Experimental Cell Research, 253, 131 142.
19. Golub, T.R., Barker, G.F., Lovett, M. Gilliland, D.G. (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell, 77, 307 316.
20. Harbott, J., Viehmann, S., Borkhardt, A., Henze, G. Lampert, F. (1997) Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood, 90, 4933 4937.
21. Harms, D.O. Janka-Schaub, G.E. (2000) Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 89 and 92. Leukemia, 14, 2234 2239.
22. Heldin, C.H., Ernlund, A., Rorsman, C. Ronnstrand, L. (1989) Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. Journal of Biological Chemistry, 264, 8905 8912.
23. Hiebert, S.W., Sun, W., Davis, J.N., Golub, T., Shurtleff, S., Buijs, A., Downing, J.R., Grosveld, G., Roussell, M.F., Gilliland, D.G., Lenny, N. Meyers, S. (1996) The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Molecular and Cellular Biology, 16, 1349 1355.
24. Huang, E.J. Reichardt, L.F. (2001) Neurotrophins: roles in neuronal development and function. Annual Review of Neuroscience, 24, 677 736.
25. Innominato, P.F., Libbrecht, L. van den Oord, J.J. (2001) Expression of neurotrophins and their receptors in pigment cell lesions of the skin. Journal of Pathology, 194, 95 100.
26. Janka-Schaub, G.E., Harms, D., Goebel, U., Graubner, U., Gutjahr, P., Haas, R.J., Juergens, H., Spaar, H.J. Winkler, K. (1996) Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood - follow up after 9 years. Coall Study Group. European Journal of Pediatrics, 155, 640 648.
27. Janka-Schaub, G.E., Harms, D.O., den Boer, M.L., Veerman, A.J. Pieters, R. (1999) In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97. Klinische Padiatrie, 211, 233 238.
28. Kaebisch, A., Brokt, S., Seay, U., Lohmeyer, J., Jaeger, U. Pralle, H. (1996) Expression of the nerve growth factor receptor c-TRK in human myeloid leukaemia cells. British Journal of Haematology, 95, 102 109.
29. Kaplan, D.R., Hempstead, B.L., Martin-Zanca, D., Chao, M.V. Parada, L.F. (1991a) The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science, 252, 554 558.
30. Kaplan, D.R., Martin-Zanca, D. Parada, L.F. (1991b) Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature, 350, 158 160.
31. Kendall, S.E., Goldhawk, D.E., Kubu, C., Barker, P.A. Verdi, J.M. (2002) Expression analysis of a novel p75(NTR) signaling protein, which regulates cell cycle progression and apoptosis. Mechanisms of Development, 117, 187 200.
32. Khwaja, F., Tabassum, A., Allen, J. Djakiew, D. (2006) The p75(NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells. Biochemical and Biophysical Research Communications, 341, 1184 1192.
33. Kimata, H., Yoshida, A., Ishioka, C. Mikawa, H. (1991) Nerve growth factor inhibits immunoglobulin production by but not proliferation of human plasma cell lines. Clinical Immunology and Immunopathology, 60, 145 151.
34. Krygier, S. Djakiew, D. (2002) Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells. International Journal of Cancer, 98, 1 7.
35. Kuner, P. Hertel, C. (1998) NGF induces apoptosis in a human neuroblastoma cell line expressing the neurotrophin receptor p75NTR. Journal of Neuroscience Research, 54, 465 474.
36. Lee, R., Kermani, P., Teng, K.K. Hempstead, B.L. (2001) Regulation of cell survival by secreted proneurotrophins. Science, 294, 1945 1948.
37. Lewin, G.R. Barde, Y.A. (1996) Physiology of the neurotrophins. Annual Review of Neuroscience, 19, 289 317.
38. Lo Coco, F., Pisegna, S. Diverio, D. (1997) The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias. Haematologica, 82, 364 370.
39. Loh, M.L., Silverman, L.B., Young, M.L., Neuberg, D., Golub, T.R., Sallan, S.E. Gilliland, D.G. (1998) Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia. Blood, 92, 4792 4797.
40. Lowdell, M.W., Lamb, L., Hoyle, C., Velardi, A. Prentice, H.G. (2001) Non-MHC-restricted cytotoxic cells: their roles in the control and treatment of leukaemias. British Journal of Haematology, 114, 11 24.
41. Matsuda, H., Coughlin, M.D., Bienenstock, J. Denburg, J.A. (1988) Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proceedings of the National Academy of Sciences of the United States of America, 85, 6508 6512.
42. Miknyoczki, S.J., Lang, D., Huang, L., Klein-Szanto, A.J., Dionne, C.A. Ruggeri, B.A. (1999) Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior. International Journal of Cancer, 81, 417 427.
43. Moricke, A., Zimmermann, M., Reiter, A., Gadner, H., Odenwald, E., Harbott, J., Ludwig, W.D., Riehm, H. Schrappe, M. (2005) Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia data from the trials ALL-BFM 90, and 95. Klinische Padiatrie, 217, 310 320.
44. Mulloy, J.C., Jankovic, V., Wunderlich, M., Delwel, R., Cammenga, J., Krejci, O., Zhao, H., Valk, P.J., Lowenberg, B. Nimer, S.D. (2005) AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion. Proceedings of the National Academy of Sciences of the United States of America, 102, 4016 4021.
45. Otten, U., Ehrhard, P. Peck, R. (1989) Nerve growth factor induces growth and differentiation of human B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 86, 10059 10063.
46. Pierotti, M.A. Greco, A. (2006) Oncogenic rearrangements of the NTRK1/NGF receptor. Cancer Letters, 232, 90 98.
47. Rabizadeh, S., Oh, J., Zhong, L.T., Yang, J., Bitler, C.M., Butcher, L.L. Bredesen, D.E. (1993) Induction of apoptosis by the low-affinity NGF receptor. Science, 261, 345 348.
48. Reuther, G.W., Lambert, Q.T., Caligiuri, M.A. Der, C.J. (2000) Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia. Molecular and Cellular Biology, 20, 8655 8666.
49. Ricci, A., Greco, S., Mariotta, S., Felici, L., Bronzetti, E., Cavazzana, A., Cardillo, G., Amenta, F., Bisetti, A. Barbolini, G. (2001) Neurotrophins and neurotrophin receptors in human lung cancer. American Journal of Respiratory Cell and Molecular Biology, 25, 439 446.
50. Roux, P.P. Barker, P.A. (2002) Neurotrophin signaling through the p75 neurotrophin receptor. Progress in Neurobiology, 67, 203 233.
51. Rubin, J.B. Segal, R.A. (2003) Growth, survival and migration: the Trk to cancer. Cancer Treatment and Research, 115, 1 18.
52. Santambrogio, L., Benedetti, M., Chao, M.V., Muzaffar, R., Kulig, K., Gabellini, N. Hochwald, G. (1994) Nerve growth factor production by lymphocytes. Journal of Immunology, 153, 4488 4495.
53. Sartorius, U., Schmitz, I. Krammer, P.H. (2001) Molecular mechanisms of death-receptor-mediated apoptosis. Chembiochem, 2, 20 29.
54. Schetelig, J., Kiani, A., Schmitz, M., Ehninger, G. Bornhauser, M. (2005) T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation. Cancer Immunology, Immunotherapy, 54, 1043 1058.
55. Seeger, K., Adams, H.P., Buchwald, D., Beyermann, B., Kremens, B., Niemeyer, C., Ritter, J., Schwabe, D., Harms, D., Schrappe, M. Henze, G. (1998) ETV6-RUNX11 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Munster Study Group. Blood, 91, 1716 1722.
56. Simone, M.D., De Santis, S., Vigneti, E., Papa, G., Amadori, S. Aloe, L. (1999) Nerve growth factor: a survey of activity on immune and hematopoietic cells. Hematological Oncology, 17, 1 10.
57. Sortino, M.A., Condorelli, F., Vancheri, C., Chiarenza, A., Bernardini, R., Consoli, U. Canonico, P.L. (2000) Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors. Molecular Endocrinology, 14, 124 136.
58. Torcia, M., Bracci-Laudiero, L., Lucibello, M., Nencioni, L., Labardi, D., Rubartelli, A., Cozzolino, F., Aloe, L. Garaci, E. (1996) Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell, 85, 345 356.
59. Vega, J.A., Garcia-Suarez, O., Hannestad, J., Perez-Perez, M. Germana, A. (2003) Neurotrophins and the immune system. Journal of Anatomy, 203, 1 19.
60. Volosin, M., Song, W., Almeida, R.D., Kaplan, D.R., Hempstead, B.L. Friedman, W.J. (2006) Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins. Journal of Neuroscience, 26, 7756 7766.
61. Wiesmann, C. de Vos, A.M. (2001) Nerve growth factor: structure and function. Cellular and Molecular Life Sciences, 58, 748 759.